NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I have no worries about this because they have had shorts on their back since Cofnate, got scrutiny from the SEC because of complaints from shorts, put in additional protections in terms of contracts and the contract they have in place was the base contract from Cognate as this was a subsidiary. Typically extending such contracts is very simple and the terms described and the baseline contract when I reviewed the old contract were exactly the same. Obviously you modify the new details and you address things like new costs and inflation. This development occurred in NWBO’s facilities. It’s a positive that they have commercial manufacturing not just approved, but can manufacture and provide DCVax-L under the UK Compassionate Use “Specials” program.